Abnormalities in HNF4a are commonly associated with a high incidence of maturity-onset diabetes of the young (MODY), with MODY1 patients exhibiting defects in insulin secretion stimulated by glucose and arginine, indicating a progressive loss of pancreatic β-cell function (49). The gene discussed is INS; the disease is maturity-onset diabetes of the young.